-
group
-
Disease Group 1-ALL, 2-AML Low Risk, 3-AML High Risk
-
t1
-
Time To Death Or On Study Time
-
t2
-
Disease Free Survival Time (Time To Relapse, Death Or End Of Study)
-
d1
-
Death Indicator 1-Dead 0-Alive
-
d2
-
Relapse Indicator 1-Relapsed, 0-Disease Free
-
d3
-
Disease Free Survival Indicator 1-Dead Or Relapsed, 0-Alive Disease Free)
-
ta
-
Time To Acute Graft-Versus-Host Disease
-
da
-
Acute GVHD Indicator 1-Developed Acute GVHD 0-Never Developed Acute GVHD)
-
tc
-
Time To Chronic Graft-Versus-Host Disease
-
dc
-
Chronic GVHD Indicator 1-Developed Chronic GVHD 0-Never Developed Chronic GVHD
-
tp
-
Time To Chronic Graft-Versus-Host Disease
-
dp
-
Platelet Recovery Indicator 1-Platelets Returned To Normal, 0-Platelets Never Returned to Normal
-
z1
-
Patient Age In Years
-
z2
-
Donor Age In Years
-
z3
-
Patient Sex: 1-Male, 0-Female
-
z4
-
Donor Sex: 1-Male, 0-Female
-
z5
-
Patient CMV Status: 1-CMV Positive, 0-CMV Negative
-
z6
-
Donor CMV Status: 1-CMV Positive, 0-CMV Negative
-
z7
-
Waiting Time to Transplant In Days
-
z8
-
FAB: 1-FAB Grade 4 Or 5 and AML, 0-Otherwise
-
z9
-
Hospital: 1-The Ohio State University, 2-Alferd , 3-St. Vincent, 4-Hahnemann
-
z10
-
MTX Used as a Graft-Versus-Host- Prophylactic: 1-Yes 0-No
